IL10 and Alzheimer disease: Regarding this anti-inflammatory cytokine, our results showed that in the AD-MSCs group, a significant elevation in IL-10 expression was observed after 1 week, which indicates the impact of AD-MSCs in down-regulation of the immune system to avoid rejection after allogeneic AD-MSCs transplantation.